5 EASY FACTS ABOUT ABBV-744 COMBINATION THERAPY WITH CHEMOTHERAPY DESCRIBED

In Section A, individuals will receive distinctive doses and schedules of oral ABBV-744 pill to recognize Protected dosing program. Supplemental participants will be enrolled within the determined monotherapy dosign regimen. In Section B, individuals will acquire oral ruxolitinib and ABBV-744 might be presented as "increase-on" therapy. In Segment